| Year |
Citation |
Score |
| 2025 |
Lim B, Xu J, Wierzbicki IH, Gonzalez CG, Chen Z, Gonzalez DJ, Gao X, Goodman AL. A human gut bacterium antagonizes neighboring bacteria by altering their protein-folding ability. Cell Host & Microbe. PMID 39909037 DOI: 10.1016/j.chom.2025.01.008 |
0.745 |
|
| 2025 |
Bayne C, McGrosso D, Sanchez C, Rossitto L-A, Patterson M, Gonzalez C, Baus C, Volk C, Zhao HN, Dorrestein P, Nizet V, Sakoulas G, Gonzalez DJ, Rose W. Multi-omic signatures of host response associated with presence, type, and outcome of enterococcal bacteremia. Msystems. e0147124. PMID 39835799 DOI: 10.1128/msystems.01471-24 |
0.587 |
|
| 2024 |
Kreimeyer H, Gonzalez CG, Fondevila MF, Hsu CL, Hartmann P, Zhang X, Stärkel P, Bosques-Padilla F, Verna EC, Abraldes JG, Brown RS, Vargas V, Altamirano J, Caballería J, Shawcross DL, et al. Faecal proteomics links neutrophil degranulation with mortality in patients with alcohol-associated hepatitis. Gut. PMID 39033024 DOI: 10.1136/gutjnl-2024-332730 |
0.313 |
|
| 2024 |
Zhuang C, Yang S, Gonzalez CG, Ainsworth RI, Li S, Kobayashi MT, Wierzbicki I, Rossitto LM, Wen Y, Peti W, Stanford SM, Gonzalez DJ, Murali R, Santelli E, Bottini N. A novel gain-of-function phosphorylation site modulates PTPN22 inhibition of TCR signaling. The Journal of Biological Chemistry. 107393. PMID 38777143 DOI: 10.1016/j.jbc.2024.107393 |
0.683 |
|
| 2024 |
Gonzalez CG, Stevens TW, Verstockt B, Gonzalez DJ, D'Haens G, Dulai PS. Crohn's Patient Serum Proteomics Reveals Response Signature for Infliximab but not Vedolizumab. Inflammatory Bowel Diseases. PMID 38367209 DOI: 10.1093/ibd/izae016 |
0.43 |
|
| 2022 |
Sauceda C, Bayne C, Sudqi K, Gonzalez A, Dulai PS, Knight R, Gonzalez DJ, Gonzalez CG. Stool multi-omics for the study of host-microbe interactions in inflammatory bowel disease. Gut Microbes. 14: 2154092. PMID 36503356 DOI: 10.1080/19490976.2022.2154092 |
0.697 |
|
| 2022 |
Gonzalez CG, Mills RH, Zhu Q, Sauceda C, Knight R, Dulai PS, Gonzalez DJ. Location-specific signatures of Crohn's disease at a multi-omics scale. Microbiome. 10: 133. PMID 35999575 DOI: 10.1186/s40168-022-01331-x |
0.74 |
|
| 2022 |
Gonzalez CG, Mills RH, Kordahi MC, Carrillo-Terrazas M, Secaira-Morocho H, Widjaja CE, Tsai MS, Mittal Y, Yee BA, Vargas F, Weldon K, Gauglitz JM, Delaroque C, Sauceda C, Rossitto LA, et al. The Host-Microbiome Response to Hyperbaric Oxygen Therapy in Ulcerative Colitis Patients. Cellular and Molecular Gastroenterology and Hepatology. PMID 35378331 DOI: 10.1016/j.jcmgh.2022.03.008 |
0.683 |
|
| 2021 |
Wedegaertner H, Pan WA, Gonzalez CC, Gonzalez DJ, Trejo J. The α-arrestin ARRDC3 is an Emerging Multifunctional Adaptor Protein in Cancer. Antioxidants & Redox Signaling. PMID 34465145 DOI: 10.1089/ars.2021.0193 |
0.362 |
|
| Show low-probability matches. |